Gut-associated bacterial microbiota in paediatric patients with inflammatory bowel disease

Gut

Volumn 55, Issue 12, 2006, Pages 1760-1767

  Conte, M P ^a   Schippa, S ^a   Zamboni, I ^a   Penta, M ^a   Chiarini, F ^a   Seganti, L ^a   Osborn, J ^a   Falconieri, P ^a   Borrelli, O ^a   Cucchiara, S ^a  

^a SAPIENZA UNIVERSITY OF ROME   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIAL DNA;

ADOLESCENT; ARTICLE; BACTERIUM CULTURE; BACTEROIDES VULGATUS; CHILD; CLINICAL ARTICLE; COLONOSCOPY; CONTROLLED STUDY; CROHN DISEASE; ENTERITIS; GENE AMPLIFICATION; HUMAN; HUMAN TISSUE; INTESTINE BIOPSY; INTESTINE FLORA; LYMPHOID HYPERPLASIA; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; ULCERATIVE COLITIS;

ADOLESCENT; BACTERIA, AEROBIC; BACTERIA, ANAEROBIC; BACTEROIDES; CECUM; CHILD; CHILD, PRESCHOOL; COLITIS; COLITIS, ULCERATIVE; CROHN DISEASE; DNA, BACTERIAL; HUMANS; HYPERPLASIA; ILEUM; INFLAMMATORY BOWEL DISEASES; INTESTINAL MUCOSA; POLYMERASE CHAIN REACTION; RECTUM;

EID: 33845454742     PISSN: 00175749     EISSN: None     Source Type: Journal    
DOI: 10.1136/gut.2005.078824     Document Type: Article

References (44)

1. Dunne C. Adaptation of bacteria to the intestinal niche: probiotics and gut disorders. Inflamm Bowel Dis 2001;7:136-45.
2. Hooper LV, Gordon JI. Commensal host-bacterial relationships in the gut. Science 2001;292:1115-18.
3. Shanahan F. The host-microbe interface within the gut. Best Pract Res Clin Gastroenterol 2002;16:915-31.
4. Holm H, Powrie F. Dendritic cells and intestinal bacterial flora: a role for localized mucosal immune response. J Clin Invest 2003;112:648-51.
5. Guarner F, Malagelada JR. Gut flora in health and disease. Lancet 2003;361:512-19.
6. Marteau P, Lepage P, Mangin I, et al. Gut flora and inflammatory bowel disease. Aliment Pharmacol Ther 2004;20:18-23.
7. Pirzer U, Schonhaar A, Fleischer B, et al. Reactivity of infiltrating T lymphocytes with microbial antigens in Crohn's disease. Lancet 1991;338:1238-9.
8. Macpherson A, Khoo UY, Forgacs I, et al. Mucosal antibodies in inflammatory bowel disease are directed against intestinal bacteria. Gut 1996;38:365-75.
9. Furrie E, Macfarlane S, Cummings JH, et al. Systemic antibodies towards mucosal bacteria in ulcerative colitis and Crohn's disease differentially activate the innate immune response. Gut 2004;53:91-8.
10. Hausmann M, Kiessling S, Mestermann S, et al. Toll-like receptors 2 and 4 are up-regulated during intestinal inflammation. Gastroenterology 2002;122:1987-2000.
11. Hugot JP, Chamaillard M, Zouali H, et al. Association of NOD2 leucine-rich repeat variants with susceptibility to Crohn's disease. Nature 2001;411:599-603.
12. Swidsinski A, Ladhoff A, Pernthaler A, et al. Mucosal flora in inflammatory bowel disease. Gastroenterology 2002;122:44-54.
13. Seksik P, Rigottier-Gois L, Gramet G, et al. Alterations of the dominant faecal bacterial groups in patients with Crohn's disease of the colon. Gut 2003;52:237-42.
14. Schultsz C, Van Den Berg FM, Ten Kate FW, et al. The intestinal mucus layer from patients with inflammatory bowel disease harbours high numbers of bacteria compared with controls. Gastroenterology 1999;117:1089-97.
15. Kleessen B, Kroesen AJ, Buhr HJ, et al. Mucosal and invading bacteria in patients with inflammatory bowel disease compared with controls. Scand J Gastroenterol 2002;37:1034-41.
16. Roth HC, Wilson KH, Sartor RB. Differential induction of colitis and gastritis in HLA-B27 transgenic rats selectively colonized with Bacteroides vulgatus or Escherichia coli. Infect Immun 1999;67:2969-74.
17. Waidmann M, Bechtold O, Frick JS, et al. Bacteroides vulgatus protects against Escherichia coli-induced colitis in gnotobiotic interleukin-2 deficient mice. Gastroenterology 2003;125:162-77.
18. Darfeuille-Michaud A, Boudeau J, Bulois P, et al. High prevalence of adherent-invasive Escherichia coli associated with ileal mucosa in Crohn's disease. Gastroenterology 2004;127:412-21.
19. Boudeau J, Glasser AL, Masseret E, et al. Invasive ability of an Escherichia coli strain isolated from the ileal mucosa of a patient with Crohn's disease. Infect Immun 1999;67:4499-509.
20. Boudeau J, Barnich N, Darfeuille-Michaud A. Type 1 pili-mediated adherence of Escherichia coli strain LF82 isolated from Crohn's disease is involved in bacterial invasion of intestinal epithelial cells. Mol Microbiol 2001;39:1272-84.
21. Martin HM, Campbell BJ, Hart CA, et al. Enhanced Escherichia coli adherence and invasion in Crohn's disease and colon cancer. Gastroenterology 2004;127:80-93.
22. Tamboli CP, Neut C, Desreumaux P, et al. Dysbiosis in inflammatory bowel disease. Gut 2004;53:1-4.
23. Kokkonen J, Karttunen TJ. Lymphonodular hyperplasia on the mucosa of the lower gastrointestinal tract in children: an indication of enhanced immune response? J Pediatr Gastroenterol Nutr 2002;34:42-6.
24. Conti F, Borrelli O, Anania C, et al. Chronic intestinal inflammation and seronegative spondyloarthropathy in children. Dig Liv Dis 2005;37:761-7.
25. Geboes K, De Hertogh G. Indeterminate colitis. Inflamm Bowel Dis 2003;9:324-31.
26. Wang RF, Cao WW, Cerniglia CE. PCR detection and quantitation of predominant anaerobic bacteria in human and animal fecal samples. Appl Environ Microbiol 1996;62:1242-7.
27. Matsuki T, Watanabe K, Fujimoto J, et al. Development of 16S rRNA-gene-targeted group-specific primers for the detection and identification of predominant bacteria in human feces. Appl Environ Microbiol 2002;68:5445-51.
28. Drasar BS, Roberts AK. Control of the large bowel microflora. In: Hill MJ, Marsh PD, eds. Human microbial ecology. Boca Raton, FL: CRC Press, 1990:95-100.
29. Lepage P, Seksik P, Sutren M, et al. Biodiversity of the mucosa-associated microbiota is stable along the distal digestive tract in healthy individuals and patients with IBD. Inflamm Bowel Dis 2005;11:473-80.
30. Moore WEC, Holdeman LV. Human fecal flora: the normal flora of 20 Japanese-Hawaiians. Appl Microbiol 1974;27:961-79.
31. Haller D, Jobin C. Interaction between resident luminal bacteria and the host: can a healthy relationship turn sour? J Pediatr Gastroenterol Nutr 2004;38:123-36.
32. Elson CO, Sartor RB, Tennyson GS, et al. Experimental models of inflammatory bowel disease. Gastroenterology 1995;109:1344-67.
33. Hartley MG, Hudson MJ, Swarbrick ET, et al. The rectal mucosa-associated microflora in patients with ulcerative colitis. J Med Microbiol 1992;36:96-103.
34. Hudson MJ, Hill MJ, Elliott PR, et al. The microbial flora of the rectal mucosa and faeces of patients with Crohn's disease before and during antimicrobial chemotherapy. J Med Microbiol 1984;18:335-45.
35. Poxton IR, Brown R, Sawyerr A, et al. Mucosa-associated bacterial flora of the human colon. J Med Microbiol 1997;46:85-91.
36. Campbell BJ, Yu LG, Rhodes JM. Altered glycosylation in inflammatory bowel disease: a possible role in cancer development. Glycoconj J 2001;18:851-8.
37. Van Kruiningen HJ. Lack of support for a common etiology in Johne's disease of animals and Crohn's disease in humans. Inflamm Bowel Dis 1999;5:183-91.
38. Chen W, Li D, Wilson I, et al. Detection of Chlamydia pneumoniae by polymerase chain reaction-enzyme immunoassay in intestinal mucosal biopsies from patients with inflammatory bowel disease and controls. J Gastroenterol Hepatol 2002;17:987-993.
39. Ruseler-van Embden JG, Both-Patoir HC. Anaerobic Gram-negative faecal flora in patients with Crohn's disease and healthy subjects. Antonie Van Leeuwenhoek 1983;49:125-32.
40. Giaffer MH, Holdsworth CD, Duerden BI. The assessment of faecal flora in patients with inflammatory bowel disease by a simplified bacteriological technique. Med Microbiol 1991;35:238-43.
41. Ott SJ, Musfeldt M, Wenderoth DF, et al. Reduction in diversity of the colonic mucosa associated bacterial microflora in patients with active inflammatory bowel disease. Gut 2004;53:685-93.
42. Jacobs LR, Huber PW. Regional distribution and alterations of lectin binding to colorectal mucin in mucosal biopsies from controls and subjects with inflammatory bowel diseases. J Clin Invest 1985;75:112-18.
43. Hoskins LC, Agustines M, McKee WB, et al. Mucin degradation in human colon ecosystems. Isolation and properties of fecal strains that degrade ABH blood group antigens and oligosaccharides from mucin glycoproteins. J Clin Invest 1985;75:944-53.
44. Corfield AP, Wagner SA, Clamp GR, et al. Mucin degradation in the human colon: production, sialidase, sialate O-acetylesterase, N-acetylneuraminate lyase, arylesterase, and glycosulfatase activities by strains of fecal bacteria. Infect Immun 1998;60:3971-8.